FinscoFinsco

Hims & Hers Health (US.HIMS)

Capital Allocation Audit · Period: 2019 – 2026

$Open the interactive terminal to run `audit` and explore all dimensions.→

Key Metrics

US.HIMS · YoY: 2026 Q1 vs 2025 Q1

MetricValueYoY
FCF Conversion59.3%↑
ROE-20.6%↓
Cash Conversion-→
D/E Ratio2.54↓
Gross Margin65.2%↓
US.HIMS (Hims & Hers Health) | YoY: 2026 Q1 vs 2025 Q1


Metric            Value  YoY
----------------------------
FCF Conversion    59.3%    ↑
ROE              -20.6%    ↓
Cash Conversion       -    →
D/E Ratio          2.54    ↓
Gross Margin      65.2%    ↓
Key Metrics
US.HIMS (Hims & Hers Health) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY
----------------------------
FCF Conversion 59.3% ↑
ROE -20.6% ↓
Cash Conversion - →
D/E Ratio 2.54 ↓
Gross Margin 65.2% ↓

Audit Dimensions

Capital FlowReturnsEarning QualityDebt DisciplineMoat

Unlimited Companies

AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies